Investors

Investors Overview

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s TumorGraft Technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice followed by propagation of the resulting engraftments, or TumorGrafts, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The company uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through the company’s Personalized Oncology Solutions business.

Download the Champions Investor Presentation

 

Sign Up for Email Alerts from Champions Oncology

 Quarterly Earnings Reports

MicrophoneDownload an MP3 recording of the FY2014 Q4 Earnings Call

MicrophoneDownload an MP3 recording of the FY2014 Q3 Earnings Call

MicrophoneDownload an MP3 recording of the FY2014 Q2 Earnings Call

MicrophoneDownload an MP3 recording of the FY2014 Q1 Earnings Call

Real-Time Stock Chart

  • Champions Oncology0.790.00 0.00%

Chart of CSBR

Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology